The presentation does read really well
And hopefully CDX management provide some details / indications at the AGM about how early sales of the Pulse are going
I must say though, after being a CDX shareholder for many years, I am still not 100% sure about how they are "actually selling" the Pulse units (in terms of ongoing subscription revenue) to both "retail / one off clients" & also to doctors / clinicians etc
I understand from previous CDX presentatios that this "selling model" will probably be a bit different for retail customers versus doctors / clinicians etc - and I understood that doctors / clinicians would purchase packs of 5 x Pulse units at a discounted rate but with an attached monthly (recurring) fee
I invested in CDX primarily because of this recurring revenue streams from the Pulse, but it appears from this presentation that they are currently more focussed on selling a stack of Pulse units (see page 14) - with a "transition to a recurring revenue model" down the track ?
Is this just because they are currently focussed more on selling to the "retail / one off" clients?
Does anyone have any more clarity on this, and if possible, could someone ask at the AGM about how management expect to get recurring revenue streams from sales of the Pulse ?
Add to My Watchlist
What is My Watchlist?
